Luke F. Chen

4.5k total citations
82 papers, 3.2k citations indexed

About

Luke F. Chen is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Luke F. Chen has authored 82 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 34 papers in Infectious Diseases and 19 papers in Surgery. Recurrent topics in Luke F. Chen's work include Surgical site infection prevention (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Luke F. Chen is often cited by papers focused on Surgical site infection prevention (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antibiotic Resistance in Bacteria (14 papers). Luke F. Chen collaborates with scholars based in United States, Australia and Ukraine. Luke F. Chen's co-authors include Daniel J. Sexton, Deverick J. Anderson, Rebekah W. Moehring, Sarah S. Lewis, Becky A. Miller, Keith S. Kaye, David J. Weber, William A. Rutala, Lauren P. Knelson and Vance G. Fowler and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Luke F. Chen

77 papers receiving 3.1k citations

Peers

Countries citing papers authored by Luke F. Chen

Since Specialization

Citations

This map shows the geographic impact of Luke F. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke F. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke F. Chen more than expected).

Fields of papers citing papers by Luke F. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke F. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke F. Chen. The network helps show where Luke F. Chen may publish in the future.

Co-authorship network of co-authors of Luke F. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Luke F. Chen. A scholar is included among the top collaborators of Luke F. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke F. Chen. Luke F. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram‐Negative Bacterial Infections: A Phase 1b, Open‐Label, Single‐Dose Clinical Trial 2023 ·The Journal of Clinical Pharmacology ·John S. Bradley, (unknown), Camilla Tøndel, Emmanuel Roilides, Matthew S. Kelly, Munjal Patel, Pavan Vaddady, (unknown), Ying Zhang, Amanda Paschke, Luke F. Chen	6
2	Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance 2023 ·JAC-Antimicrobial Resistance ·Jason A. Roberts, David P. Nicolau, Ignacio Martín‐Loeches, C Andrew DeRyke, Maria C Losada, Jiejun Du, Munjal Patel, Matthew L. Rizk, Amanda Paschke, Luke F. Chen	10
3	Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis 2023 ·Open Forum Infectious Diseases ·Ignacio Martín‐Loeches, Andrew F. Shorr, Marin H. Kollef, Jiejun Du, Maria C Losada, Amanda Paschke, C Andrew DeRyke, Michael Wong, Erin Jensen, Luke F. Chen	2
4	Mycobacterium avium pseudo-outbreak associated with an outpatient bronchoscopy clinic: Lessons for reprocessing 2018 ·Infection Control and Hospital Epidemiology ·Jessica Seidelman, Richard J. Wallace, Elena Iakhiaeva, Ravikiran Vasireddy, Barbara A. Brown‐Elliott, (unknown), Luke F. Chen, Terry Smith, Sarah S. Lewis	14
5	Self-monitoring by Environmental Services May Not Accurately Measure Thoroughness of Hospital Room Cleaning 2017 ·Infection Control and Hospital Epidemiology ·Lauren P. Knelson, (unknown), Luke F. Chen, Rebekah W. Moehring, Sarah S. Lewis, William A. Rutala, David J. Weber, Daniel J. Sexton, Deverick J. Anderson	15
6	Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials 2016 ·American Journal of Infection Control ·David J. Weber, William A. Rutala, Deverick J. Anderson, Luke F. Chen, Emily Sickbert-Bennett, John M. Boyce	143
7	Evaluation of Community-Acquired Clostridium difficile Infection in North Carolina Using Geographic Information Systems and Spatial Statistics 2015 ·Open Forum Infectious Diseases ·(unknown), (unknown), Lauren P. Knelson, (unknown), Sarah S. Lewis, Rebekah W. Moehring, Luke F. Chen, Daniel J. Sexton, Deverick J. Anderson	0
8	Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Surveillance: National Healthcare Safety Network’s Laboratory-Identified Event Reporting versus Traditional Laboratory-Confirmed Bloodstream Infection Surveillance 2014 ·Infection Control and Hospital Epidemiology ·Arthur W. Baker, Michael J. Durkin, Kristen V. Dicks, Sarah S. Lewis, Rebekah W. Moehring, Luke F. Chen, Daniel J. Sexton, Deverick J. Anderson	3
9	Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis 2013 ·Expert Opinion on Pharmacotherapy ·(unknown), Luke F. Chen	8
10	The Epidemiology of Ventilator-Associated Pneumonia in a Network of Community Hospitals: A Prospective Multicenter Study 2013 ·Infection Control and Hospital Epidemiology ·Mi Suk Lee, (unknown), Luke F. Chen, Daniel J. Sexton, Deverick J. Anderson	33
11	Comparison of Non–Intensive Care Unit (ICU) versus ICU Rates of Catheter-Associated Urinary Tract Infection in Community Hospitals 2013 ·Infection Control and Hospital Epidemiology ·Sarah S. Lewis, Lauren P. Knelson, Rebekah W. Moehring, Luke F. Chen, Daniel J. Sexton, Deverick J. Anderson	28
12	The changing epidemiology of methicillin-resistant Staphylococcus aureus: 50 years of a superbug 2012 ·American Journal of Infection Control ·Luke F. Chen	20
13	Observing and Improving Hand Hygiene Compliance Implementation and Refinement of an Electronic-Assisted Direct-Observer Hand Hygiene Audit Program 2012 ·Infection Control and Hospital Epidemiology ·Luke F. Chen, (unknown), (unknown), (unknown), (unknown), Becky A. Miller, Deverick J. Anderson, Rebekah W. Moehring, (unknown), (unknown), (unknown), (unknown), Daniel J. Sexton	52
14	Facing the rising tide of multidrug resistant Gram-negative pathogens 2011 ·Luke F. Chen, Matthew E. Falagas, Anton Y. Peleg	1
15	Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients—North Carolina, 2009 2011 ·The Journal of Infectious Diseases ·Luke F. Chen, Natalie Dailey Garnes, Agam K. Rao, Aaron T. Fleischauer, (unknown), Varough Deyde, Zack Moore, Deverick J. Anderson, Jonathan Duffy, Larisa V. Gubareva, Daniel J. Sexton, Alicia M. Fry, Arjun Srinivasan, Cameron R. Wolfe	68
16	Ceftaroline fosamil for treatment of communityacquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy 2011 ·Expert Review of Anti-infective Therapy ·(unknown), Richard H. Drew, Luke F. Chen	3
17	Community-Acquired Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections: Management and Prevention 2011 ·Current Infectious Disease Reports ·Luke F. Chen, Cody A. Chastain, Deverick J. Anderson	11
18	Patient-days: A better measure of incidence of occupational bloodborne exposures 2009 ·American Journal of Infection Control ·Luke F. Chen, Daniel J. Sexton, Keith S. Kaye, Deverick J. Anderson	6
19	Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study 2009 ·PLoS ONE ·Deverick J. Anderson, Keith S. Kaye, Luke F. Chen, Kenneth E. Schmader, Yong Choi, Richard Sloane, Daniel J. Sexton	165
20	What's New in Rocky Mountain Spotted Fever? 2008 ·Infectious Disease Clinics of North America ·Luke F. Chen, Daniel J. Sexton	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact